Filing Details

Accession Number:
0000899243-20-017601
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-24 21:17:27
Reporting Period:
2020-06-23
Accepted Time:
2020-06-24 21:17:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1538927 Forma Therapeutics Holdings Inc. FMTX Biological Products, (No Disgnostic Substances) (2836) 371657129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1814683 Paolo Paoletti C/O Forma Therapeutics Holdings, Inc.
500 Arsenal Street, Suite 100
Watertown MA 02472
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-23 45,553 $0.00 45,553 No 4 P Direct
Enterprise 2 Junior Stock Disposition 2020-06-23 25,248 $0.00 0 No 4 S Direct
Enterprise 3 Junior Stock Disposition 2020-06-23 9,847 $0.00 0 No 4 S Direct
Enterprise 4 Junior Stock Disposition 2020-06-23 10,240 $0.00 0 No 4 S Direct
Enterprise 5 Junior Stock Disposition 2020-06-23 14,026 $0.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Effective immediately upon the closing of the Registrant's initial public offering on June 23, 2020, the reporting person converted (i) 25,248 shares of Enterprise 2 Junior Stock at a conversion rate of 0.8179 shares of common stock per one share of Enterprise 2 Junior Stock, (ii) 9,847 shares of Enterprise 3 Junior Stock at a conversion rate of 0.7822 shares of common stock per one share of Enterprise 3 Junior Stock, (iii) 10,240 shares of Enterprise 4 Junior Stock at a conversion rate of 0.7585 shares of common stock per one share of Enterprise 4 Junior Stock, and (iv) 14,026 shares of Enterprise 5 Junior Stock at a conversion rate of 0.6727 shares of common stock per one share of Enterprise 5 Junior Stock, resulting in his acquisition of 45,553 shares of common stock.